Clinical trial
Preventing Staphylococcal (Staph) Infection
NCT00108160 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108160 |
|---|---|
| Title | Preventing Staphylococcal (Staph) Infection |
| Official title | Intermittent Mupirocin to Prevent Staphylococcal Infection |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | University of Michigan Trinity Health Michigan |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Staphylococcal Infections |
| Intervention type | Drug |
| Interventions | Mupirocin Ointment [Treatment], Polyethylene Glycol Ointment [Placebo] |
| Enrollment | 146 |
| Start date | Apr 1, 2005 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Apr 15, 2005 |
| Last update posted | Apr 16, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: